If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it ...

There were empty seats in San Francisco last week at an annual international science conference which has delivered some of ...

Since 1993, groundbreaking HIV science has been presented here. Research that proved that a cocktail of three antiretroviral (ARV) drugs could lower the amount of virus in someone’s body to virtually ...

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives and putting HIV prevention at risk ...

Read more: USAID funding cuts jeopardize breakthrough drugs and research Will infants finally have access to a highly effective HIV drug?

Hollyoaks star Paul Danan, 46, died from a fatal drug cocktail, an inquest revealed. The actor battled addiction for years and was due in court days before his tragic death. Listen to Story Actor Paul ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are deemed to be at high risk of contracting the human immunodeficiency ...

US freeze has upended global medical supply chains HIV exempted, but USAID payments system down About $10 million needed to distribute warehouse stock NAIROBI, March 11 (Reuters) - The health ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet, external medical journal.

Queer HIV activist opens up about Trump and Musk's USAID cuts Ruele Okeyo posts videos of himself on TikTok taking his HIV medication. He says it is to reduce the stigma around it.

UCSF researchers are the first to demonstrate that the approach works for the patients who need it the most. Patients who struggle to take daily HIV pills can benefit from long-acting injectable ...